These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☐
|
Preliminary
Proxy Statement
|
|
☐
|
Confidential,
For use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
☒
|
Definitive
Proxy Statement
|
|
☐
|
Definitive
Additional Materials
|
|
☐
|
Soliciting
Material Pursuant to §240.14a-12
|
|
☒
|
No fee
required.
|
|
|
☐
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
|
|
|
|
|
|
(1)
|
Title
of each class of securities to which transaction
applies:
|
|
|
|
|
|
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11(set forth the amount on
which the filing fee is calculated and state how it was
determined):
|
|
|
|
|
|
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
|
|
|
(5)
|
Total
fee paid
|
|
|
|
|
|
|
|
|
|
☐
|
Fee
paid previously with preliminary materials:
|
|
|
|
|
|
|
|
|
|
|
☐
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
|
|
|
|
|
|
|
(1)
|
Amount
previously paid:
|
|
|
|
|
|
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
|
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
|
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
|
|
Dear Fellow
LightPath Stockholders:
|
October 1,
2020
|
|
|
|
|
By Internet
Visit
www.AALvote.com/LPTH
|
By Phone
Call
the telephone number on your proxy card, voting instruction form,
or notice
|
By Mail
Sign,
date, and return the enclosed proxy card or voting instruction
form
|
|
/s/ Shmuel Rubin
|
/s/ Robert Ripp
|
|
Shmuel
Rubin
|
Robert
Ripp
|
|
President
& Chief Executive Officer, Director
|
Chairman
of the Board
|
|
Proposal
|
Board Recommendation
|
Voting Choices
|
|
Vote Required for Adoption
|
|
Effect of Abstentions
|
|
Effect of Broker Non-Votes
|
|
1 – Election of Director Nominees
|
FOR
each nominee
|
●
Vote
“For” any or all of the nominees listed
●
Vote
“Withhold” to withhold your vote for any or all of the
nominees listed
|
|
Plurality
of the votes of the shares present in person or by proxy and
entitled to vote at the Annual Meeting
|
|
No
effect
|
|
No
effect
|
|
|
|
|
|
|
|
|
|
|
|
2 – Approval of the compensation of our named executive
officers
|
FOR
|
●
Vote
“For” the approval of the compensation of our named
executive officers
●
Vote
“Against” the approval of the compensation of our named
executive officers
●
Abstain from voting
on this proposal
|
|
Approved,
on a non-binding advisory basis, if a majority of the shares
present in person or represented by proxy and entitled to vote
support the proposal
|
|
Treated
as votes against proposal
|
|
No
effect
|
|
|
|
|
|
|
|
|
|
|
|
3 – Ratification of the appointment of MSL as our independent
registered public accounting firm
|
FOR
|
●
Vote
“For” the ratification of the appointment
●
Vote
“Against” the ratification of the
appointment
●
Abstain from voting
on this proposal
|
|
Approved,
on a non-binding advisory basis, if a majority of the shares
present in person or represented by proxy and entitled to vote
support the proposal
|
|
Treated
as votes against proposal
|
|
Brokers
have discretion to vote
|
|
Name
|
Audit
|
Compensation
|
Finance
|
Nominating & Corporate Governance
|
Class
|
|
Robert Ripp
|
|
☑
|
☑
|
☑
|
I
|
|
Darcie Peck
|
☑
|
|
|
|
I
|
|
Dr. Joseph Menaker
|
|
|
☑
|
|
I
|
|
Sohail Khan
|
|
☑
|
☑
|
☑
|
II
|
|
Dr. Steven Brueck
|
☑
|
|
|
|
II
|
|
M. Scott Faris
|
☑
|
|
☑
|
|
II
|
|
Louis Leeburg
|
☑
|
☑
|
|
☑
|
III
|
|
Craig Dunham
|
☑
|
|
|
|
III
|
|
Shmuel Rubin
|
|
|
|
|
III
|
|
Committee Chairman:
|
Leeburg
|
Ripp
|
Khan
|
Ripp
|
|
|
Nominees for Class III Directors
|
|
|
Louis
Leeburg, 66
Director
|
Mr.
Leeburg has served as one of our directors since May 1996. Mr.
Leeburg is currently a self-employed business consultant. Since
1993, Mr. Leeburg has served as the senior financial advisor of The
Fetzer Institute, and before that, he served as the Vice President
for Finance. Mr. Leeburg was an audit manager for Price Waterhouse
& Co. until 1980. He is a member of the Financial Foundation
Officers Group and the chairman and trustee for the John E. Fetzer
Memorial Trust Fund. Mr. Leeburg received a Bachelor of Science
degree in Accounting from Arizona State University.
Mr. Leeburg has a broad range of experience in accounting and
financial matters. His expertise gained in various roles in
financial management and investment oversight for over thirty
years, coupled with his knowledge gained as a certified public
accountant, add invaluable knowledge to our Board and qualify him
for service as one of our directors.
|
|
Craig
Dunham, 64
Director
|
Mr.
Dunham has served as one of our directors since April 2016, and
prior to his appointment to the Board, he served as a consultant to
the Board beginning in March 2014. Since April 2015, he provides
business and M&A consulting to companies. From May 2011 until
March 2015, Mr. Dunham served as the Chief Executive Officer of
Applied Pulsed Power Inc. (“APP”), a pulsed power
components and systems company near Ithaca, New York. Mr. Dunham
currently serves as a director of APP. From 2004 until 2011, Mr.
Dunham was President, Chief Executive Officer and director of
Dynasil Corporation of America (“Dynasil”), a company
which was previously listed on the Nasdaq Capital Market until
August 2019, and now is quoted on the OTC Markets Group,
Inc.’s Pink Open Market. He continues to be a director at
Dynasil and is a member of their audit committee. Prior to joining
Dynasil, Mr. Dunham spent approximately one year partnering with a
private equity group to pursue acquisitions of mid-market
manufacturing companies. From 2000 to 2003, he was Vice
President/General Manager of the Tubular Division at Kimble Glass
Corporation. From 1979 to 2000, he held progressively increasing
leadership responsibilities at Corning Incorporated
(“Corning”) in manufacturing, engineering, commercial,
and general management positions. At Corning, Mr. Dunham delivered
results in various glass and ceramics businesses including optics
and photonics businesses. Mr. Dunham earned a Bachelor of Science
degree in Mechanical Engineering and a Master’s degree in
Business Administration from Cornell University. Mr. Dunham’s
expertise in executive leadership, financial, strategic planning,
operations and management, business acumen, optics/photonics market
knowledge, and knowledge of the acquisitions process, qualifies him
for service as one of our directors.
|
|
|
|
|
Shmuel
Rubin, 46
President
& Chief Executive Officer, Director
|
Mr.
Rubin has served as our President, Chief Executive Officer, and as
a Director since March 2020. Mr. Rubin is also a director of
LightPath Optical Instrumentation (Shanghai) Co., Ltd.
(“LPOI”), our wholly-owned subsidiary, located in
Jiading, People’s Republic of China, LightPath Optical
Instrumentation (Zhenjiang) Co., Ltd. (“LPOIZ”), our
wholly-owned subsidiary, located in the New City District, of the
Jiangsu province of the People’s Republic of China, ISP, our
wholly-owned subsidiary, previously located in Irvington, New York,
and ISP Latvia, our wholly-owned subsidiary located in Riga,
Latvia.
Prior
to joining us, Mr. Rubin was formerly General Manager at Thorlabs
Inc. (“Thorlabs”). In Mr. Rubin’s prior senior
executive role at Thorlabs, he was responsible for Thorlabs’
Imaging Systems Division, a standalone organization with its own
sales and marketing, as well as global responsibility for all of
Thorlabs’ Life Science activities. Among the positions he
held at Thorlabs, Mr. Rubin founded and grew Thorlabs’s fast
growing operation in China, and spearheaded Thorlabs’ entry
and significant growth in the Life Sciences market. As a member of
the senior executive team, Mr. Rubin led new strategic initiatives
for Thorlabs, including new product lines, acquisitions and growth
into new markets. Prior to joining Thorlabs, Mr. Rubin co-founded
XLight Photonics, an optical communication startup, which was later
sold to a telecommunications private equity firm. Mr. Rubin holds a
Bachelor of Science degree in Electronic Engineering from Ben
Gurion University, a Master of Business Administration degree from
New York University, Stern School of Business, and is a graduate of
the Executive Education, Program for Leadership Development at
Harvard Business School. Mr. Rubin’s significant management
experience in the optical industry qualifies him to lead us and our
business and service as one of our directors.
|
|
Sohail
Khan, 66
Director
|
Mr.
Khan has served as one of our directors since February 2005. Since
September 2017, he has served as the managing partner of K5
Innovations, a technology consulting venture. He also served in
such role from July 2011 to April 2013. He served as the President
and Chief Executive Officer of ViSX Systems Inc., a pioneer and
leader in media processing semiconductor solutions for video over
IP streaming solutions from September 2015 until the company was
acquired by Pixelworks in August 2017. From May 2013 to July 2014,
he served as the Chief Executive Officer and a director of
Lilliputian Systems, a developer of portable power products for
consumer electronics. He was the President and Chief Executive
Officer and a member of the board of directors of SiGe
Semiconductor (“SiGe”), a leader in silicon-based radio
frequency front-end solutions from April 2007 until it was acquired
by Skyworks Solutions Inc. in June 2011. Prior to SiGe, Mr. Khan
was Entrepreneur in Residence and Operating Partner of Bessemer
Venture Partners, a venture capital group focused on technology
investments. Mr. Khan received a Bachelor of Science in Electrical
Engineering from the University of Engineering and Technology in
Pakistan. Additionally, he received a Master’s of Business
Administration from the University of California at Berkeley. Mr.
Khan previously served on the board of directors and audit
committee of Intersil Corporation, a public company, from October
2014 to March 2017, and the board of directors of VIXS Systems,
Inc., a public company, until the acquisition by Renesas &
Pixelworks in August 2017. Mr. Khan’s experience in venture
financing, specifically technology investments, is an invaluable
asset Mr. Khan contributes to the Board composition. In addition,
Mr. Khan’s significant 35 years of experience in executive
management, particularly with respect to technology businesses,
profit and loss management, mergers and acquisitions, and capital
raising, as well as his background in engineering qualifies him for
service as one of our directors.
|
|
|
|
|
Dr.
Steven Brueck, 76
Director
|
Dr.
Brueck has served as one of our directors since July 2001. Since
July 2017, he has served as Vice President and Chief Scientific
Officer at Armonica Technologies, Inc., a venture capital-backed
company formed to commercialize his University of New Mexico
patents in nanofluidics and long-read DNA sequencing. He is a
Distinguished Professor, Emeritus of Electrical and Computer
Engineering and of Physics at the University of New Mexico in
Albuquerque, New Mexico, which he joined in 1985. Although he
retired in 2014, he remains active as a University of New Mexico
Research Professor. From 1986 to 2013, he served as Director of the
Center for High Technology Materials. Since 2016, he has served on
the Scientific Advisory Committee for the Center for Integrated
Nanotechnologies of Sandia National Laboratories. He is a graduate
of Columbia University with a Bachelor of Science degree in
Electrical Engineering and a graduate of the Massachusetts
Institute of Technology where he received his Master’s and
Doctorate of Science degrees in Electrical Engineering. Dr. Brueck
is a fellow of The Optical Society of America, the Institute of
Electrical and Electronics Engineers, the American Association for
the Advancement of Science, and the National Academy of Inventors.
Dr. Brueck’s expertise in optics and optics applications, as
well as his extensive fifty years of research experience in optics,
lasers, detectors, lithography, nonlinear optics, and related
fields qualify him for service as one of our
directors.
|
|
|
|
|
M.
Scott Faris, 55
Director
|
Mr.
Faris has served as a director of the Company since December 2011.
Mr. Faris is an experienced entrepreneur with almost two decades of
operating, venture-financing, and commercialization experience,
involving more than 20 start-up and emerging-growth technology
companies. In September 2016, Mr. Faris was named the Chief
Business Officer of Luminar Technologies, Inc., a leading developer
of autonomous vehicle systems technologies including Lidar sensor
suites. In June 2013, Mr. Faris founded Aerosonix, Inc. (formerly
MicroVapor Devices, LLC), a privately held developer and
manufacturer of advanced medical devices, and served as its Chief
Executive Officer until August 2016 and has served as Chairman of
the board of directors since June 2013. In 2002, Mr. Faris also
founded the Astralis Group, a strategy advisor that provides
consulting to start-up companies and, since 2004, Mr. Faris has
served as its Chief Executive Officer. In August 2007, Mr. Faris
founded Planar Energy, a company that developed transformational
ceramic solid-state battery technology and products, and served as
its Chief Executive Officer until June 2013. Planar Energy is a
spin-out of the U.S. Department of Energy’s National
Renewable Energy Laboratory. From October 2004 to June 2007, Mr.
Faris was a partner with Corporate IP Ventures (formerly known as
MetaTech Ventures), an early stage venture fund specializing in
defense technologies. Mr. Faris also previously served as the
Chairman and Chief Executive Officer of Waveguide Solutions, a
developer of planar optical light wave circuit and micro system
products, and as a director and Chief Operating Officer of Ocean
Optics, Inc., a precision-optical-component and
fiber-optic-instrument spin-out of the University of South Florida.
Mr. Faris was also the founder and Chief Executive Officer of
Enterprise Corporation, a technology accelerator, served as a
director of the Florida Seed Capital Fund and Technology
Commercialization at the Center for Microelectronics Research, and
the chairman of the Metro Orlando EDC. Mr. Faris received a
Bachelor of Science degree in Management Information Systems from
Penn State University in 1988. Mr. Faris is currently on the board
of directors of Aerosonix, Inc., a private company. Mr.
Faris’s significant experience in executive management
positions at various optical component companies, his experience in
the commercialization of optical and opto-electronic component
technology, and his background in optics, technology, and venture
capital qualify him for service as one of our
directors.
|
|
Donald
O. Retreage, Jr., 66
Chief
Financial Officer
|
Mr.
Retreage was appointed as our Chief Financial Officer on June 18,
2018. He most recently served as Senior Vice President of Houser
Logistics from April 2017 to June 2018, where he was responsible
for aligning strategic initiatives with corporate targets for
customer service, revenue, and cost control. Prior to that, during
a portion of 2017, Mr. Retreage was a Financial Specialist at
Robert Half / Accountemps, and from October 2016 to January 2017,
Mr. Retreage served as a Senior Business Consultant for
International Services Inc., during which he worked with business
owners to develop management processes, practices, and policies to
drive profitability and grow businesses. From 2008 to 2015, Mr.
Retreage served as Deputy Managing Director & Financial
Director at Seaboard Management Corporation, a division of Seaboard
Corporation. He received a Bachelor of Science in Business
Administration, Accounting and Finance from University of Louisiana
at Lafayette. Mr. Retreage is experienced in directing
international business operations and aligning strategic
initiatives with corporate targets for revenue, cost control, and
employee development and engagement.
|
|
|
|
|
Robert
Ripp
|
Sohail
Khan
|
|
Steven
Brueck
|
Louis
Leeburg
|
|
M.
Scott Faris
|
Craig
Dunham
|
|
Darcie
Peck
|
|
|
|
Securities
|
|
|
|||
|
|
Class A Common
Stock
|
|
|
|
|
|
|
Name
and Address (1)
|
Restricted
(2)
|
Unrestricted
|
Options
|
Amount of Shares
of Class A Common Stock Beneficially Owned
|
|
Percent
Owned
(%) |
|
Robert Ripp,
Director
|
396,954
|
775,000
|
—
|
1,171,954
|
(3
)
|
4.4
%
|
|
Louis Leeburg,
Director
|
396,954
|
102,691
|
—
|
499,645
|
(4
)
|
1.9
%
|
|
Sohail Khan,
Director
|
398,154
|
20,661
|
—
|
418,815
|
|
1.6
%
|
|
Dr. Steven Brueck,
Director
|
396,954
|
79,870
|
—
|
476,824
|
(5
)
|
1.8
%
|
|
M. Scott Faris,
Director
|
296,254
|
3,940
|
—
|
300,194
|
|
1.1
%
|
|
Craig Dunham,
Director
|
205,794
|
33,000
|
—
|
238,794
|
|
*
|
|
Dr. Joseph Menaker,
Director
|
80,787
|
—
|
—
|
80,787
|
|
*
|
|
Darcie Peck,
Director
|
48,000
|
—
|
—
|
48,000
|
|
*
|
|
Shmuel Rubin,
CEO
|
—
|
14,320
|
—
|
14,320
|
|
*
|
|
Donald Retreage,
Jr., CFO
|
—
|
3,750
|
5,886
|
9,636
|
(6
)
|
*
|
|
All
directors and executive officers as a group (10
persons)
|
2,219,851
|
1,033,232
|
5,886
|
3,258,969
|
|
11.5
%
|
|
|
|
|
|
|
|
|
|
J. James Gaynor,
Former CEO
|
—
|
216,978
|
406,606
|
623,584
|
(7
)
|
*
|
|
Alan Symmons,
Former COO
|
—
|
41,200
|
—
|
41,200
|
(8
)
|
*
|
|
Greater
than 5% beneficial owners:
|
|
|
|
|
|
|
|
Pudong Science and
Technology Investment (Cayman) Co., Ltd.
|
—
|
2,270,026
|
—
|
2,270,026
|
(9
)
|
8.7
%
|
|
Royce &
Associates, LP
|
—
|
1,350,084
|
—
|
1,350,084
|
|
5.2
%
|
|
Name
(1)
|
Class A common
stock
|
Stock Options
(2)
|
Restricted Stock
Units
|
Total Amount of
Shares of Class A Common Stock Beneficially Owned
|
Stock Price at
June 30, 2020
|
Market Value at
June 30, 2020
|
Base
Salary
|
% of
Salary
|
|
Shmuel
Rubin
|
11,320
|
118,243
|
100,000
|
229,563
|
$
3.33
|
$
764,445
|
$
350,000
|
218
%
|
|
Donald O. Retreage,
Jr.
|
3,750
|
7,097
|
—
|
10,847
|
$
3.33
|
$
36,121
|
$
200,000
|
18
%
|
|
Number of Points Earned
|
Percentage of Payout of the 2019 LT Multi-Year Award
|
|
0-3
|
0%
|
|
4
|
50%
|
|
5
|
60%
|
|
6
|
75%
|
|
7
|
100%
|
|
8
|
110%
|
|
9
|
125%
|
|
Number of Points Earned
|
Percentage of Payout of the 2019 LT Multi-Year Award
|
|
0-3
|
0%
|
|
4
|
50%
|
|
5
|
60%
|
|
6
|
75%
|
|
7
|
100%
|
|
8
|
110%
|
|
9
|
125%
|
|
|
|
|
|
|
|
|
|
Non-Equity
Incentive
|
|
|
|
|
|
Fiscal
|
Salary
|
|
Stock
Awards
|
|
Option
Awards
|
|
Plan
Compensation
|
|
All
Other
Compensation
|
Total
|
|
Name and
Position
|
Year
|
($)
|
|
($) (1)
|
|
($) (2)
|
|
($)
|
|
($) (3)
|
($)
|
|
(a)
|
(b)
|
(c)
|
|
(e)
|
|
(f)
|
|
(g)
|
|
(i)
|
(j)
|
|
Shmuel
RubinPresident &
|
2020
|
105,464
|
(4
)
|
139,000
|
(4
)
|
197,987
|
(4
)
|
100,000
|
(4
)
|
48,075
|
590,526
|
|
Chief Executive
Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
J. James
Gaynor
|
2020
|
315,000
|
(5
)
|
—
|
|
—
|
|
43,000
|
(8
)
|
59,222
|
417,222
|
|
Former President
& Chief Executive Officer
|
2019
|
315,000
|
(5
)
|
—
|
|
—
|
|
—
|
|
18,771
|
333,771
|
|
Donald O. Retreage,
Jr.
|
2020
|
200,000
|
(6
)
|
—
|
|
5,200
|
(8
)
|
28,800
|
(8
)
|
10,694
|
244,694
|
|
Chief Financial
Officer
|
2019
|
200,000
|
(6
)
|
—
|
|
1,258
|
(9
)
|
—
|
|
33,052
|
241,252
|
|
Alan
Symmons
|
2020
|
209,288
|
(7
)
|
—
|
|
—
|
|
—
|
|
36,180
|
245,468
|
|
Former Chief
Operating Officer
|
2019
|
210,000
|
(7
)
|
—
|
|
1,534
|
(9
)
|
—
|
|
17,077
|
237,077
|
|
Stock Option
Grants
|
|
Compensation
Expense (1)
|
||||||
|
|
|
|
|
Actual
|
Projected
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
Fiscal
2024
|
|
Grant
Date
|
of
Shares
|
Vested
Shares
|
|
$
|
$
|
$
|
$
|
$
|
|
2/24/2020
|
225,000
|
44
|
(2
)
|
$
18,334
|
$
43,997
|
$
43,997
|
$
53,162
|
$
38,497
|
|
|
|
|
|
|
|
|
|
|
|
RSUs
|
|
|
|
|
|
|
||
|
2/24/2020
|
100,000
|
-
|
(3
)
|
$
9,654
|
$
23,169
|
$
23,169
|
$
42,470
|
$
40,538
|
|
Stock Option
Grants
|
|
Compensation
Expense (1)
|
||||||
|
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number
of
|
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant
Date
|
of
Shares
|
Vested
Shares
|
|
$
|
$
|
$
|
$
|
$
|
|
6/15/2018
|
10,000
|
5,000
|
(2
)
|
$
2,206
|
$
2,206
|
$
2,206
|
$
2,021
|
$
-
|
|
11/14/2019
|
6,407
|
-
|
(3
)
|
-
|
280
|
419
|
419
|
140
|
|
|
|
|
|
$
2,206
|
$
2,486
|
$
2,625
|
$
2,440
|
$
140
|
|
|
Option
Awards
|
RSU
Awards
|
||||||
|
|
|
|
|
|
|
|
|
(h)
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
(b)
|
(c)
|
|
|
|
|
(g)
|
Value of
|
|
|
Number
of
|
Number
of
|
|
|
|
|
Number of
|
Shares or
|
|
|
Securities
|
Securities
|
|
|
|
|
Shares
or
|
Units
of
|
|
|
Underlying
|
Underlying
|
(e)
|
|
|
(f)
|
Units
of
|
Stock
|
|
|
Unexercised
|
Unexercised
|
Option
|
|
|
Option
|
Stock That
|
That
|
|
(a)
|
Options
(#)
|
Options
(#)
|
Exercise
|
Vesting
|
|
Expiration
|
Have
Not
|
Have
Not
|
|
Name
|
Exercisable
|
Unexercisable
|
Price
($)
|
Schedule
|
|
Date
|
Vested
|
Vested
|
|
Shmuel Rubin (1)
|
—
|
225,000
|
$
1.58
|
50,000 shares/yr for 3 yrs;
75,000 shares on 4th anniversary
|
|
2/24/2030
|
100,000
|
$
333,000
|
|
Donald Retreage, Jr.
(2)
|
3,750
|
5,000
|
$
2.13
|
25%/yr for 4
yrs
|
|
6/18/2028
|
—
|
—
|
|
|
—
|
6,407
|
$
1.28
|
33%/yr for 3
yrs
|
|
11/14/2029
|
—
|
—
|
|
J. James Gaynor
(3)
|
40,000
|
—
|
$
1.39
|
25%/yr for 4
yrs
|
|
10/27/2021
|
—
|
—
|
|
|
50,000
|
—
|
$
1.41
|
25%/yr for 4
yrs
|
|
10/31/2023
|
—
|
—
|
|
|
50,000
|
—
|
$
1.37
|
25%/yr for 4
yrs
|
|
10/30/2024
|
—
|
—
|
|
|
23,000
|
—
|
$
1.48
|
25%/yr for 4
yrs
|
|
10/29/2025
|
—
|
—
|
|
|
55,556
|
—
|
$
1.48
|
immediate
|
|
10/29/2025
|
—
|
—
|
|
|
45,654
|
15,216
|
$
1.78
|
25%/yr for 4
yrs
|
|
10/27/2026
|
—
|
—
|
|
|
117,108
|
—
|
$
1.56
|
immediate
|
|
10/27/2026
|
—
|
—
|
|
|
19,196
|
9,599
|
$
4.24
|
33%/yr for 3
yrs
|
|
10/26/2027
|
—
|
—
|
|
|
6,092
|
—
|
$
2.10
|
immediate
|
|
11/15/2028
|
—
|
—
|
|
Alan Symmons (4)
|
7,000
|
—
|
$
2.69
|
25%/yr for 4
yrs
|
|
11/3/2020
|
—
|
—
|
|
|
12,500
|
—
|
$
1.39
|
25%/yr for 4
yrs
|
|
10/27/2021
|
—
|
—
|
|
|
12,500
|
—
|
$
0.98
|
25%/yr for 4
yrs
|
|
10/25/2022
|
—
|
—
|
|
|
4,000
|
—
|
$
0.87
|
25%/yr for 4
yrs
|
|
1/31/2023
|
—
|
—
|
|
|
15,000
|
—
|
$
1.41
|
25%/yr for 4
yrs
|
|
10/31/2023
|
—
|
—
|
|
|
15,000
|
—
|
$
1.37
|
25%/yr for 4
yrs
|
|
10/30/2024
|
—
|
—
|
|
|
10,000
|
—
|
$
1.27
|
25%/yr for 4
yrs
|
|
1/12/2025
|
—
|
—
|
|
|
29,762
|
—
|
$
1.48
|
immediate
|
|
10/29/2025
|
—
|
—
|
|
|
7,000
|
—
|
$
1.48
|
25%/yr for 4
yrs
|
|
10/29/2025
|
—
|
—
|
|
|
41,824
|
—
|
$
1.56
|
immediate
|
|
10/27/2026
|
—
|
—
|
|
|
16,305
|
5,434
|
$
1.78
|
25%/yr for 4
yrs
|
|
10/27/2026
|
—
|
—
|
|
|
6,856
|
3,428
|
$
4.24
|
33%/yr for 3
yrs
|
|
10/26/2027
|
—
|
—
|
|
|
2,437
|
—
|
$
2.10
|
immediate
|
|
11/15/2028
|
—
|
—
|
|
|
—
|
7,813
|
$
1.28
|
33%/yr for 3
yrs
|
|
11/14/2029
|
—
|
—
|
|
|
Fees Earned or
|
Stock
|
All
Other
|
Total
|
|
|
Paid in
Cash
|
Awards
|
Compensation
|
($)
|
|
Name
(1)
|
($)(2)
|
($)(3)
|
($)
|
|
|
(a)
|
(b)
|
(c)
|
(g)
|
(h)
|
|
Robert
Ripp
|
$
100,000
|
$
29,520
|
$
-
|
$
129,520
|
|
Sohail
Khan
|
$
40,000
|
$
29,520
|
$
-
|
$
69,520
|
|
Dr. Steven
Brueck
|
$
36,000
|
$
29,520
|
$
-
|
$
65,520
|
|
Louis
Leeburg
|
$
44,000
|
$
29,520
|
$
-
|
$
73,520
|
|
M. Scott
Faris
|
$
36,000
|
$
29,520
|
$
-
|
$
65,520
|
|
Craig
Dunham
|
$
36,000
|
$
29,520
|
$
-
|
$
65,520
|
|
Dr. Joseph
Menaker
|
$
36,000
|
$
29,520
|
$
-
|
$
65,520
|
|
Darcie
Peck
|
$
36,000
|
$
29,520
|
$
-
|
$
65,520
|
|
(1)
|
Shmuel
Rubin, our President and Chief Executive Officer during a portion
of fiscal 2020, is not included in this table as he was an employee
and, thus, received no compensation for his services as a director.
The compensation received by Mr. Rubin as an employee is disclosed
in the Summary Compensation Table on page 26.
|
|
(2)
|
Total
fees earned for fiscal 2020 includes all fees earned, including
earned but unpaid fees. The amounts of unpaid fees for each
director are as follows: Mr. Ripp - $25,000, Mr. Leeburg - $11,000,
Dr. Brueck - $9,000, Mr. Khan - $10,000, Mr. Faris - $9,000, Mr.
Dunham - $9,000, Dr. Menaker - $9,000 and Ms. Peck -
$9,000.
|
|
(3)
|
The
table reflects the fair value amount for RSUs granted for the
fiscal year ended June 30, 2020 in accordance with ASC Topic
718. The directors were entitled to a restricted stock award equal
to $60,000. The Company has a policy of granting
performance-related stock options and RSUs at the greater of the
closing bid price of our Class A common stock on the grant date or
the book value per share of our Class A common stock as of the end
of the most recent fiscal quarter. The fiscal 2020 director award
of 48,000 RSUs was based on the book value of $1.25 per share as of
September 30, 2019, the most recent quarter preceding the grant
date, whereas the closing bid price of our Class A common stock on
the grant date was $0.62.
|
|
Name
|
Board Fee
|
Chairman Fee
|
Committee Chair Fee
|
Total Fees Earned for Fiscal Year 2020
|
|
Robert
Ripp
|
$
36,000
|
$
60,000
|
$
4,000
|
$
100,000
|
|
Sohail
Khan
|
$
36,000
|
|
$
4,000
|
$
40,000
|
|
Dr.
Steven Brueck
|
$
36,000
|
|
|
$
36,000
|
|
Louis
Leeburg
|
$
36,000
|
|
$
8,000
|
$
44,000
|
|
M.
Scott Faris
|
$
36,000
|
|
|
$
36,000
|
|
Craig
Dunham
|
$
36,000
|
|
|
$
36,000
|
|
Dr.
Joseph Menaker
|
$
36,000
|
|
|
$
36,000
|
|
Darcie
Peck
|
$
36,000
|
|
|
$
36,000
|
|
Shmuel
Rubin (1)
|
$
-
|
|
|
$
-
|
|
|
Restricted
Stock Units
|
||
|
Name of Director
(1)
|
Number of Units
Granted
|
Grant
Date
|
Fair Value Per
Share
|
|
Robert
Ripp
|
48,000
|
11/14/2019
|
$
0.62
|
|
Sohail
Khan
|
48,000
|
11/14/2019
|
$
0.62
|
|
Dr. Steven
Brueck
|
48,000
|
11/14/2019
|
$
0.62
|
|
Louis
Leeburg
|
48,000
|
11/14/2019
|
$
0.62
|
|
M. Scott
Faris
|
48,000
|
11/14/2019
|
$
0.62
|
|
Craig
Dunham
|
48,000
|
11/14/2019
|
$
0.62
|
|
Dr. Joseph
Menaker
|
48,000
|
11/14/2019
|
$
0.62
|
|
Darcie
Peck
|
48,000
|
11/14/2019
|
$
0.62
|
|
|
384,000
|
|
|
|
RSUs
|
Compensation
Expense (1)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal 2022
|
Fiscal
2023
|
|
Grant Date
|
of Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/29/2015
|
33,785
|
33,785
|
$
4,165
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/27/2016
|
38,462
|
38,462
|
19,999
|
4,998
|
-
|
-
|
-
|
|
10/26/2017
|
16,260
|
10,840
|
20,000
|
19,992
|
4,996
|
-
|
-
|
|
11/15/2018
|
32,787
|
10,929
|
13,335
|
20,000
|
20,000
|
6,665
|
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
57,499
|
$
51,552
|
$
34,836
|
$
16,505
|
$
3,279
|
|
Positions:
|
Chairman of the
Board, Compensation Committee Chairman, Nominating & Corporate
Governance
|
|
Committees:
|
Committee
Chairman
Compensation,
Finance and Nominating & Corporate Governance
Committees
|
|
RSUs
|
Compensation
Expense (1)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant
Date
|
of Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/29/2015
|
33,785
|
33,785
|
$
4,165
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/27/2016
|
38,462
|
38,462
|
19,999
|
4,998
|
-
|
-
|
-
|
|
10/26/2017
|
16,260
|
10,840
|
20,000
|
19,992
|
4,996
|
-
|
-
|
|
11/15/2018
|
32,787
|
10,929
|
13,335
|
20,000
|
20,000
|
6,665
|
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
57,499
|
$
51,552
|
$
34,836
|
$
16,505
|
$
3,279
|
|
Positions:
|
Finance Committee
Chairman
|
|
Committees:
|
Finance,
Compensation and Nominating & Corporate Governance
Committees
|
|
RSUs
|
Compensation
Expense (1)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant Date
|
of Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/29/2015
|
33,785
|
33,785
|
$
4,165
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/27/2016
|
38,462
|
38,462
|
19,999
|
4,998
|
-
|
-
|
-
|
|
10/26/2017
|
16,260
|
10,840
|
20,000
|
19,992
|
4,996
|
-
|
-
|
|
11/15/2018
|
32,787
|
10,929
|
13,335
|
20,000
|
20,000
|
6,665
|
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
57,499
|
$
51,552
|
$
34,836
|
$
16,505
|
$
3,279
|
|
RSUs
|
Compensation
Expense (1)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant
Date
|
of Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/29/2015
|
33,785
|
33,785
|
$
4,165
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/27/2016
|
38,462
|
38,462
|
19,999
|
4,998
|
-
|
-
|
-
|
|
10/26/2017
|
16,260
|
10,840
|
20,000
|
19,992
|
4,996
|
-
|
-
|
|
11/15/2018
|
32,787
|
10,929
|
13,335
|
20,000
|
20,000
|
6,665
|
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
57,499
|
$
51,552
|
$
34,836
|
$
16,505
|
$
3,279
|
|
Positions:
|
Audit Committee
Chairman
|
|
Committees:
|
Audit, Compensation
and Nominating & Corporate Governance Committees
|
|
RSUs
|
Compensation
Expense (1)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant
Date
|
of Shares
|
Vested Shares
(2)
|
$
|
$
|
$
|
$
|
$
|
|
10/29/2015
|
33,785
|
33,785
|
$
4,165
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/27/2016
|
38,462
|
38,462
|
19,999
|
4,998
|
-
|
-
|
-
|
|
10/26/2017
|
16,260
|
10,840
|
20,000
|
19,992
|
4,996
|
-
|
-
|
|
11/15/2018
|
32,787
|
10,929
|
13,335
|
20,000
|
20,000
|
6,665
|
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
57,499
|
$
51,552
|
$
34,836
|
$
16,505
|
$
3,279
|
|
RSUs
|
Compensation
Expense (2)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant Date
|
of Shares
|
Vested Shares
(3)
|
$
|
$
|
$
|
$
|
$
|
|
10/29/2015
|
33,785
|
33,785
|
$
4,165
|
$
-
|
$
-
|
$
-
|
$
-
|
|
10/27/2016
|
38,462
|
38,462
|
19,999
|
4,998
|
-
|
-
|
-
|
|
10/26/2017
|
16,260
|
10,840
|
20,000
|
19,992
|
4,996
|
-
|
-
|
|
11/15/2018
|
32,787
|
10,929
|
13,335
|
20,000
|
20,000
|
6,665
|
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
57,499
|
$
51,552
|
$
34,836
|
$
16,505
|
$
3,279
|
|
RSUs
|
Compensation
Expense (2)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant Date
|
of Shares
|
Vested Shares
(3)
|
$
|
$
|
$
|
$
|
$
|
|
11/15/2018
|
32,787
|
10,929
|
$
13,335
|
$
20,000
|
$
20,000
|
$
6,665
|
$
-
|
|
11/14/2019
|
48,000
|
-
|
-
|
6,561
|
9,840
|
9,840
|
3,279
|
|
|
|
|
$
13,335
|
$
26,561
|
$
29,840
|
$
16,505
|
$
3,279
|
|
RSUs
|
Compensation
Expense (2)
|
||||||
|
|
|
|
Actual
|
Actual
|
Projected
|
Projected
|
Projected
|
|
|
Number
|
Number of
|
Fiscal
2019
|
Fiscal
2020
|
Fiscal
2021
|
Fiscal
2022
|
Fiscal
2023
|
|
Grant
Date
|
of Shares
|
Vested Shares
(3)
|
$
|
$
|
$
|
$
|
$
|
|
11/14/2019
|
48,000
|
-
|
$
-
|
$
6,561
|
$
9,840
|
$
9,840
|
$
3,279
|
|
Plan
category
|
Number of securities
to be issued upon exercise of outstanding options, warrants and
rights
|
Weighted average
exercise and grant price of outstanding options, warrants and
rights
|
Number of securities
remaining available for future issuance
|
|
Equity compensation
plans approved by security holders
|
3,262,426
(1)
|
$
2.09
(2)
|
930,326
|
|
Equity compensation
plans not approved by security holders
|
—
|
—
|
—
|
|
|
Fiscal
2020
|
Fiscal
2019
|
|
Audit Fees
(1)
|
$
152,300
|
$
152,200
|
|
Tax Fees
(2)
|
22,500
|
20,000
|
|
All Other Fees
(3)
|
5,500
|
2,925
|
|
Total
All Fees
|
$
180,300
|
$
175,125
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|